Scott Wolbach
About Scott Wolbach
Scott Wolbach is a Manager and Project Planning Lead in Oncology R&D Strategy & Planning at Bristol-Myers Squibb, with extensive experience in managing projects related to Oncology, Cardiovascular, and Autoimmune diseases.
Title
Scott Wolbach is the Manager and Project Planning Lead for Oncology R&D Strategy & Planning at Bristol-Myers Squibb. He is based in the Tampa/St. Petersburg, Florida Area.
Education and Expertise
Scott Wolbach holds an MBA in Management from Saint Joseph's University, where he studied from 2006 to 2008. He also holds a Bachelors of Business Administration in Finance/Business Administration from the University of St. Thomas. His academic background has equipped him with the skills necessary for his role in the pharmaceutical industry.
Company
Scott Wolbach is currently part of Bristol-Myers Squibb, specifically in the Oncology R&D Strategy & Planning division. The company is a global biopharmaceutical leader known for its work in cancer, cardiovascular, autoimmune diseases, and more. He operates from the Tampa/St. Petersburg area.
Background
Scott Wolbach has significant experience managing projects related to Oncology, Cardiovascular, and Autoimmune diseases. He leads a team of three R&D Strategy & Planning project planners and is responsible for ensuring that Clinical R&D processes and SOPs comply with current regulations. He collaborates closely with various stakeholders to maintain high standards in project timelines, risk management, and data quality.
Responsibilities
In his current role, Scott Wolbach develops and maintains standards and tools for project timelines, project risk management, and data quality in collaboration with the Capability Steward. He provides constructive feedback and coaching to his staff to ensure optimal performance. His responsibilities also include maintaining strong working relationships with project managers, master project planners, business process leaders, clinical operations, clinical data, finance, and protocol managers.